Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases

摘要

Compositions and methods for the treatment of glaucoma and other ocular diseases are disclosed. The compositions and methods are particularly directed to the use inhibitors of Jun N-terminal kinases (JNK), such as SP600125 in the treatment of glaucoma and other ocular diseases.